,address1,city,state,zip,country,phone,fax,website,industry,sector,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,exDividendDate,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,265 Watline Avenue,Mississauga,ON,L4Z 1P3,Canada,905 361 8910,905 361 8911,https://microbix.com,Biotechnology,Healthcare,"Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.","{'maxAge': 1, 'name': 'Mr. Cameron L. Groome', 'title': 'Pres, CEO & Director', 'fiscalYear': 2022, 'totalPay': 441482, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.295,0.3,0.28,0.3,0.295,0.3,0.28,0.3,936230400,0.0,0.103481,9.666667,287500,287500,37138,49260,49260,0.28,0.285,0,0,39818160,0.28,0.53,2.401636,0.3236,0.37005,0.0,0.0,CAD,33660236,-0.15084,117140800,137304000,22237,23782,1690761600,1693440000,0.0002,0.13539,0.00914,0.6,0.165,1.7575756,1664496000,1696032000,1688083200,-2500836,-0.02,0.03,2.03,-25.594,TOR,EQUITY,MBX.TO,MBX.TO,MICROBIX J,Microbix Biosystems Inc.,839943000,America/Toronto,EDT,-14400000,0.29,1.0,0.8,0.9,0.9,2.0,buy,2,13409156,0.098,-1315160,6564749,3.142,4.391,16579599,28.992,0.12,-0.03704,-0.105550006,11124842,-379394,508071,0.104,0.48715,-0.07932,-0.120799996,CAD,
1,265 Watline Avenue,Mississauga,ON,L4Z 1P3,Canada,905 361 8910,905 361 8911,https://microbix.com,Biotechnology,Healthcare,"Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.","{'maxAge': 1, 'name': 'Mr. James S. Currie', 'title': 'Chief Financial Officer', 'fiscalYear': 2022, 'totalPay': 284598, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.295,0.3,0.28,0.3,0.295,0.3,0.28,0.3,936230400,0.0,0.103481,9.666667,287500,287500,37138,49260,49260,0.28,0.285,0,0,39818160,0.28,0.53,2.401636,0.3236,0.37005,0.0,0.0,CAD,33660236,-0.15084,117140800,137304000,22237,23782,1690761600,1693440000,0.0002,0.13539,0.00914,0.6,0.165,1.7575756,1664496000,1696032000,1688083200,-2500836,-0.02,0.03,2.03,-25.594,TOR,EQUITY,MBX.TO,MBX.TO,MICROBIX J,Microbix Biosystems Inc.,839943000,America/Toronto,EDT,-14400000,0.29,1.0,0.8,0.9,0.9,2.0,buy,2,13409156,0.098,-1315160,6564749,3.142,4.391,16579599,28.992,0.12,-0.03704,-0.105550006,11124842,-379394,508071,0.104,0.48715,-0.07932,-0.120799996,CAD,
2,265 Watline Avenue,Mississauga,ON,L4Z 1P3,Canada,905 361 8910,905 361 8911,https://microbix.com,Biotechnology,Healthcare,"Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.","{'maxAge': 1, 'name': 'Dr. Kenneth  Hughes Ph.D.', 'title': 'Chief Operating Officer', 'fiscalYear': 2022, 'totalPay': 283939, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.295,0.3,0.28,0.3,0.295,0.3,0.28,0.3,936230400,0.0,0.103481,9.666667,287500,287500,37138,49260,49260,0.28,0.285,0,0,39818160,0.28,0.53,2.401636,0.3236,0.37005,0.0,0.0,CAD,33660236,-0.15084,117140800,137304000,22237,23782,1690761600,1693440000,0.0002,0.13539,0.00914,0.6,0.165,1.7575756,1664496000,1696032000,1688083200,-2500836,-0.02,0.03,2.03,-25.594,TOR,EQUITY,MBX.TO,MBX.TO,MICROBIX J,Microbix Biosystems Inc.,839943000,America/Toronto,EDT,-14400000,0.29,1.0,0.8,0.9,0.9,2.0,buy,2,13409156,0.098,-1315160,6564749,3.142,4.391,16579599,28.992,0.12,-0.03704,-0.105550006,11124842,-379394,508071,0.104,0.48715,-0.07932,-0.120799996,CAD,
3,265 Watline Avenue,Mississauga,ON,L4Z 1P3,Canada,905 361 8910,905 361 8911,https://microbix.com,Biotechnology,Healthcare,"Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.","{'maxAge': 1, 'name': 'Dr. Mark  Luscher Ph.D.', 'title': 'Sr. VP of Scientific Affairs', 'fiscalYear': 2022, 'totalPay': 257488, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.295,0.3,0.28,0.3,0.295,0.3,0.28,0.3,936230400,0.0,0.103481,9.666667,287500,287500,37138,49260,49260,0.28,0.285,0,0,39818160,0.28,0.53,2.401636,0.3236,0.37005,0.0,0.0,CAD,33660236,-0.15084,117140800,137304000,22237,23782,1690761600,1693440000,0.0002,0.13539,0.00914,0.6,0.165,1.7575756,1664496000,1696032000,1688083200,-2500836,-0.02,0.03,2.03,-25.594,TOR,EQUITY,MBX.TO,MBX.TO,MICROBIX J,Microbix Biosystems Inc.,839943000,America/Toronto,EDT,-14400000,0.29,1.0,0.8,0.9,0.9,2.0,buy,2,13409156,0.098,-1315160,6564749,3.142,4.391,16579599,28.992,0.12,-0.03704,-0.105550006,11124842,-379394,508071,0.104,0.48715,-0.07932,-0.120799996,CAD,
4,265 Watline Avenue,Mississauga,ON,L4Z 1P3,Canada,905 361 8910,905 361 8911,https://microbix.com,Biotechnology,Healthcare,"Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.","{'maxAge': 1, 'name': 'Mr. Philip  Casselli', 'title': 'Sr. VP of Sales, Bus. Devel. & Marketing', 'fiscalYear': 2022, 'totalPay': 272657, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.295,0.3,0.28,0.3,0.295,0.3,0.28,0.3,936230400,0.0,0.103481,9.666667,287500,287500,37138,49260,49260,0.28,0.285,0,0,39818160,0.28,0.53,2.401636,0.3236,0.37005,0.0,0.0,CAD,33660236,-0.15084,117140800,137304000,22237,23782,1690761600,1693440000,0.0002,0.13539,0.00914,0.6,0.165,1.7575756,1664496000,1696032000,1688083200,-2500836,-0.02,0.03,2.03,-25.594,TOR,EQUITY,MBX.TO,MBX.TO,MICROBIX J,Microbix Biosystems Inc.,839943000,America/Toronto,EDT,-14400000,0.29,1.0,0.8,0.9,0.9,2.0,buy,2,13409156,0.098,-1315160,6564749,3.142,4.391,16579599,28.992,0.12,-0.03704,-0.105550006,11124842,-379394,508071,0.104,0.48715,-0.07932,-0.120799996,CAD,
5,265 Watline Avenue,Mississauga,ON,L4Z 1P3,Canada,905 361 8910,905 361 8911,https://microbix.com,Biotechnology,Healthcare,"Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.","{'maxAge': 1, 'name': 'Mr. Christopher B. Lobb', 'title': 'Compliance Officer, Gen. Counsel & Sec.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.295,0.3,0.28,0.3,0.295,0.3,0.28,0.3,936230400,0.0,0.103481,9.666667,287500,287500,37138,49260,49260,0.28,0.285,0,0,39818160,0.28,0.53,2.401636,0.3236,0.37005,0.0,0.0,CAD,33660236,-0.15084,117140800,137304000,22237,23782,1690761600,1693440000,0.0002,0.13539,0.00914,0.6,0.165,1.7575756,1664496000,1696032000,1688083200,-2500836,-0.02,0.03,2.03,-25.594,TOR,EQUITY,MBX.TO,MBX.TO,MICROBIX J,Microbix Biosystems Inc.,839943000,America/Toronto,EDT,-14400000,0.29,1.0,0.8,0.9,0.9,2.0,buy,2,13409156,0.098,-1315160,6564749,3.142,4.391,16579599,28.992,0.12,-0.03704,-0.105550006,11124842,-379394,508071,0.104,0.48715,-0.07932,-0.120799996,CAD,
